A Review of Anticancer Potential of Conferone, Diversin and Ferutinin; Which One is Stronger for Cancer Therapy?


如何引用文章

全文:

详细

Background:One of the growing diseases in today's human societies is cancer, which has become a major challenge, especially in industrialized and developing countries. Cancer treatments are diverse, but they usually use surgery, chemotherapy, and radiotherapy to improve patients. Existing drugs are usually expensive and, in some cases, are not effective due to drug resistance and side effects. Finding compounds of natural origin can be somewhat effective and useful in helping doctors to treat this disease. Ferula plants, which are traditionally used as spices or for medicinal purposes, can be a good source for finding anti-cancer compounds due to their various compounds, such as monoterpenes, sulfide compounds, and polyphenols. Several studies have shown that compounds found in Ferula plants have significant anticancer effects on various types of cancer cells.

Objective:This article was compiled with the aim of collecting evidence and articles related to the anti-cancer effects of three compounds obtained from these plants, namely Conferone, Diversin, and Ferutinin.

Methods:This review article was prepared by searching the terms Conferone, Diversin, Ferutinin and cancer and related information was collected through searching electronic databases such as ISI Web of Knowledge, PubMed and Google Scholar until the March of 2024.

Conclusion:The results of this review showed that relatively comprehensive studies have been conducted in this field and these studies have shown that these compounds can be used in the design of future anticancer drugs. Among the examined compounds, conferone showed that it has the best effect on cancer cells.

作者简介

Fariborz Keshmirshekan

Yazd Neuroendocrine Research Center, Faculty of Medeicine, Shahid Sadoughi University of Medical Sciences and Health Services

Email: info@benthamscience.net

Seyed-Mahdi Mohamadi-Zarch

Yazd Neuroendocrine Research Center, Faculty of Medeicine,, Shahid Sadoughi University of Medical Sciences and Health Services

Email: info@benthamscience.net

Seyyed Bagheri

Yazd Neuroendocrine Research Center, Faculty of Medeicine, Shahid Sadoughi University of Medical Sciences and Health Services,

编辑信件的主要联系方式.
Email: info@benthamscience.net

参考

  1. Mattiuzzi, C.; Lippi, G. Current cancer epidemiology. J. Epidemiol. Glob. Health, 2019, 9(4), 217-222. doi: 10.2991/jegh.k.191008.001 PMID: 31854162
  2. Xia, C.; Dong, X.; Li, H.; Cao, M.; Sun, D.; He, S.; Yang, F.; Yan, X.; Zhang, S.; Li, N.; Chen, W. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin. Med. J., 2022, 135(5), 584-590. doi: 10.1097/CM9.0000000000002108 PMID: 35143424
  3. WHO. Diagnosis and treatment., Available from: https://www.who.int/publications/who-guidelines (accessed on 8-10-2024)
  4. Abbas, Z.; Rehman, S. An overview of cancer treatment modalities. Neoplasm, 2018, 1, 139-157.
  5. Norouzi, M.; Amerian, M.; Amerian, M.; Atyabi, F. Clinical applications of nanomedicine in cancer therapy. Drug Discov. Today, 2020, 25(1), 107-125. doi: 10.1016/j.drudis.2019.09.017 PMID: 31586642
  6. Maggiore, U.; Palmisano, A.; Buti, S.; Claire Giudice, G.; Cattaneo, D.; Giuliani, N.; Fiaccadori, E.; Gandolfini, I.; Cravedi, P. Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients? Transpl. Int., 2021, 34(12), 2442-2458. doi: 10.1111/tri.14115 PMID: 34555228
  7. Thirumalaivasan, N.; Nangan, S.; Kanagaraj, K.; Rajendran, S. Assessment of sustainability and environmental impacts of renewable energies: Focusing on biogas and biohydrogen (Biofuels) production. Process Saf. Environ. Prot., 2024, 189, 467-485. doi: 10.1016/j.psep.2024.06.063
  8. Shoker, R.M.H. A review article: The importance of the major groups of plants secondary metabolism phenols, alkaloids, and terpenes. Int. J. Res. Appl. Sci. Biotechnol., 2020, 7(5), 354-358. doi: 10.31033/ijrasb.7.5.47
  9. Doble, M. Potential synergism of natural products in the treatment of cancer. Phyther. Res. An Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv., 2006, 20, 239-249.
  10. Wang, J.; Ding, R.; Ouyang, T.; Gao, H.; Kan, H.; Li, Y.; Hu, Q.; Yang, Y. Systematic investigation of the mechanism of herbal medicines for the treatment of prostate cancer. Aging (Albany NY), 2023, 15(4), 1004-1024. doi: 10.18632/aging.204516 PMID: 36795572
  11. Baharara, H.; Rahsepar, S.; Emami, S.A.; Elyasi, S.; Mohammadpour, A.H.; Ghavami, V.; Rajendram, R.; Sahebkar, A.; Arasteh, O. The efficacy of medicinal plant preparations in the alleviation of radiodermatitis in patients with breast cancer: A systematic review of clinical trials. Phytother. Res., 2023, 37(8), 3275-3295. doi: 10.1002/ptr.7894 PMID: 37211432
  12. Kalachaveedu, M.; Senthil, R.; Azhagiyamanavalan, S.; Ravi, R.; Meenakshisundaram, H.; Dharmarajan, A. Traditional medicine herbs as natural product matrices in cancer chemoprevention: A trans pharmacological perspective (scoping review). Phytother. Res., 2023, 37(4), 1539-1573. doi: 10.1002/ptr.7747 PMID: 36788644
  13. Amiri, M.S.; Joharchi, M.R. Ethnobotanical knowledge of Apiaceae family in Iran: A review. Avicenna J. Phytomed., 2016, 6(6), 621-635. PMID: 28078243
  14. Christensen, L.P.; Brandt, K. Bioactive polyacetylenes in food plants of the apiaceae family: Occurrence, bioactivity and analysis. J. Pharm. Biomed. Anal., 2006, 41(3), 683-693. doi: 10.1016/j.jpba.2006.01.057 PMID: 16520011
  15. Moran, J.; van Rijswijk, B.; Traicevski, V.; Kitajima, E.W.; Mackenzie, A.M.; Gibbs, A.J. Potyviruses, novel and known, in cultivated and wild species of the family Apiaceae in Australia. Arch. Virol., 2002, 147(10), 1855-1867. doi: 10.1007/s00705-002-0865-8 PMID: 12376749
  16. Sirizi, M.A.G.; Alizadeh Ghalenoei, J.; Allahtavakoli, M.; Forouzanfar, H.; Bagheri, S.M. Anticancer potential of Ferula assa-foetida and its constituents, a powerful plant for cancer therapy. World J. Biol. Chem., 2023, 14(2), 28-39. doi: 10.4331/wjbc.v14.i2.28 PMID: 37034135
  17. Iranshahi, M.; Kalategi, F.; Rezaee, R.; Shahverdi, A.; Ito, C.; Furukawa, H.; Tokuda, H.; Itoigawa, M. Cancer chemopreventive activity of terpenoid coumarins from Ferula species. Planta Med., 2008, 74(2), 147-150. doi: 10.1055/s-2008-1034293 PMID: 18240102
  18. Ansari, I.A.; Akhtar, M.S. Current insights on the role of terpenoids as anticancer agents: A perspective on cancer prevention and treatment. In: Natural Bio-active Compound; Springer, 2019; Vol. 2, pp. 53-80.
  19. Neshati, V.; Matin, M.M.; Bahrami, A.R.; Iranshahi, M.; Rassouli, F.B.; Saeinasab, M. Increasing the cisplatin cytotoxicity and cisplatin-induced DNA damage by conferone in 5637 cells. Nat. Prod. Res., 2012, 26(18), 1724-1727. doi: 10.1080/14786419.2011.606546 PMID: 21988674
  20. Kasaian, J.; Mosaffa, F.; Behravan, J.; Masullo, M.; Piacente, S.; Iranshahi, M. Modulation of multidrug resistance protein 2 efflux in the cisplatin resistance human ovarian carcinoma cells A2780/RCIS by sesquiterpene coumarins. Phytother. Res., 2016, 30(1), 84-89. doi: 10.1002/ptr.5504 PMID: 26503061
  21. Khan, S.S.; Khan, A.; Marasini, B.P.; Saba, N.; Ahmad, V.U.; Iranshani, M.; Hosseini, S.T.; Choudhary, M.I. (Alpha)-chymotrypsin and urease inhibitory activity of diversolides C, D and E from the roots of Ferula diversivittata. J. Chem. Soc. Pak., 2012, 2012, 34.
  22. Luan, L.; Li, N.; Zhang, K.; Wang, X.; Pan, H. Diversin upregulates the proliferative ability of colorectal cancer by inducing cell cycle proteins. Exp. Mol. Pathol., 2023, 129, 104850. doi: 10.1016/j.yexmp.2023.104850 PMID: 36623636
  23. Naji, R.G.S.; Karimi, E.; Oskoueian, E.; Homayouni-Tabrizi, M.; Iranshahi, M. Ferutinin: A phytoestrogen from ferula and its anticancer, antioxidant, and toxicity properties. J. Biochem. Mol. Toxicol., 2021, 35(4), e22713. doi: 10.1002/jbt.22713 PMID: 33501774
  24. Junqueira, M.Z.; Chammas, R. Cancer chemotherapy failure: A synthetic view. Rev. Med., 2018, 97(2), 141-153. doi: 10.11606/issn.1679-9836.v97i2p141-153
  25. Bach-Griera, M.; Campo-Pérez, V.; Barbosa, S.; Traserra, S.; Guallar-Garrido, S.; Moya-Andérico, L.; Herrero-Abadía, P.; Luquin, M.; Rabanal, R.M.; Torrents, E.; Julián, E. Mycolicibacterium brumae is a safe and non-toxic immunomodulatory agent for cancer treatment. Vaccines, 2020, 8(2), 198. doi: 10.3390/vaccines8020198 PMID: 32344808
  26. Sauter, E.R.; Mohammed, A. Natural products for cancer prevention and interception: Preclinical and clinical studies and funding opportunities. Pharmaceuticals, 2024, 17(1), 136. doi: 10.3390/ph17010136 PMID: 38276009
  27. Tewari, D.; Rawat, P.; Singh, P.K. Adverse drug reactions of anticancer drugs derived from natural sources. Food Chem. Toxicol., 2019, 123, 522-535. doi: 10.1016/j.fct.2018.11.041 PMID: 30471312
  28. Poustforoosh, A.; Faramarz, S.; Negahdaripour, M.; Tüzün, B.; Hashemipour, H. Investigation on the mechanisms by which the herbal remedies induce anti-prostate cancer activity: uncovering the most practical natural compound. J. Biomol. Struct. Dyn., 2024, 42(7), 3349-3362. doi: 10.1080/07391102.2023.2213344 PMID: 37194430
  29. Imtiaz, I.; Schloss, J.; Bugarcic, A. Traditional and contemporary herbal medicines in management of cancer: A scoping review. J. Ayurveda Integr. Med., 2024, 15(1), 100904. doi: 10.1016/j.jaim.2024.100904 PMID: 38395014
  30. Lin, S.R.; Chang, C.H.; Hsu, C.F.; Tsai, M.J.; Cheng, H.; Leong, M.K.; Sung, P.J.; Chen, J.C.; Weng, C.F. Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence. Br. J. Pharmacol., 2020, 177(6), 1409-1423. doi: 10.1111/bph.14816 PMID: 31368509
  31. Lacey, J.; Huston, A.; Lopez, G.; Vozmediano, J.R.; Lam, C.S.; Narayanan, S.; Lu, W.; Wolf, U.; Subbiah, I.M.; Richard, P.; Lopez, A.M.; Rao, S.; Frenkel, M. Establishing an Integrative Oncology Service: Essential Aspects of Program Development. Curr. Oncol. Rep., 2024, 26(3), 200-211. doi: 10.1007/s11912-024-01504-x PMID: 38358637
  32. Muscolo, A.; Mariateresa, O.; Giulio, T.; Mariateresa, R. Oxidative stress: the role of antioxidant phytochemicals in the prevention and treatment of diseases. Int. J. Mol. Sci., 2024, 25(6), 3264. doi: 10.3390/ijms25063264 PMID: 38542238
  33. Khan, F.; Pandey, P.; Verma, M.; Ramniwas, S.; Lee, D.; Moon, S.; Park, M.N.; Upadhyay, T.K.; Kim, B. Emerging trends of phytochemicals as ferroptosis modulators in cancer therapy. Biomed. Pharmacother., 2024, 173, 116363. doi: 10.1016/j.biopha.2024.116363 PMID: 38479184
  34. Rafatpanah, H.; Golizadeh, M.; Mahdifar, M.; Mahdavi, S.; Iranshahi, M.; Rassouli, F.B. Conferone, a coumarin from Ferula flabelliloba, induced toxic effects on adult T-cell leukemia/lymphoma cells. Int. J. Immunopathol. Pharmacol., 2023, 37, 03946320231197592. doi: 10.1177/03946320231197592 PMID: 37688389
  35. Eruçar, F.M.; Kuran, F.K.; Altıparmak Ülbegi, G.; Özbey, S.; Karavuş, Ş.N.; Arcan, G.G.; Yazıcı Tütüniş, S.; Tan, N.; Aksoy Sağırlı, P.; Miski, M. Sesquiterpene coumarin ethers with selective cytotoxic activities from the roots of Ferula huber-morathii peşmen (apiaceae) and unequivocal determination of the absolute stereochemistry of samarcandin. Pharmaceuticals (Basel), 2023, 16(6), 792. doi: 10.3390/ph16060792 PMID: 37375740
  36. Barthomeuf, C.; Demeule, M.; Grassi, J.; Saidkhodjaev, A.; Beliveau, R. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport. Planta Med., 2006, 72(7), 634-639. doi: 10.1055/s-2006-931574 PMID: 16739070
  37. Li, S.; Jiang, M.; Wang, L.; Yu, S. Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement. Biomed. Pharmacother., 2020, 129, 110389. doi: 10.1016/j.biopha.2020.110389 PMID: 32540642
  38. Rahmani, A.; Rahimi, F.; Iranshahi, M.; Kahroba, H.; Zarebkohan, A.; Talebi, M.; Salehi, R.; Mousavi, H.Z. Co-delivery of doxorubicin and conferone by novel pH-responsive β-cyclodextrin grafted micelles triggers apoptosis of metastatic human breast cancer cells. Sci. Rep., 2021, 11(1), 21425. doi: 10.1038/s41598-021-00954-8 PMID: 34728703
  39. Romani, A.M.P. Cisplatin in cancer treatment. Biochem. Pharmacol., 2022, 206, 115323. doi: 10.1016/j.bcp.2022.115323 PMID: 36368406
  40. Tchounwou, P.B.; Dasari, S.; Noubissi, F.K.; Ray, P.; Kumar, S. Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy. J. Exp. Pharmacol., 2021, 13, 303-328. doi: 10.2147/JEP.S267383 PMID: 33776489
  41. Song, M.; Cui, M.; Liu, K. Therapeutic strategies to overcome cisplatin resistance in ovarian cancer. Eur. J. Med. Chem., 2022, 232, 114205. doi: 10.1016/j.ejmech.2022.114205 PMID: 35217497
  42. Rahmani, A.; Zavvar, M.H.; Salehi, R.; Bagheri, A. Novel pH-sensitive and biodegradable micelles for the combined delivery of doxorubicin and conferone to induce apoptosis in MDA-MB-231 breast cancer cell line. RSC Advances, 2020, 10(49), 29228-29246. doi: 10.1039/D0RA03467C PMID: 35521092
  43. Khalili, L.; Dehghan, G.; Hosseinpour Feizi, M.A.; Sheibani, N.; Hamishekar, H. Development of an albumin decorated lipid-polymer hybrid nanoparticle for simultaneous delivery of methotrexate and conferone to cancer cells. Int. J. Pharm., 2021, 599, 120421. doi: 10.1016/j.ijpharm.2021.120421 PMID: 33676992
  44. Chitsazian-Yazdi, M.; Agnolet, S.; Lorenz, S.; Schneider, B.; Es’haghi, Z.; Kasaian, J.; Khameneh, B.; Iranshahi, M. Foetithiophenes C-F, thiophene derivatives from the roots of Ferula foetida. Pharm. Biol., 2015, 53(5), 710-714. doi: 10.3109/13880209.2014.939765 PMID: 25430396
  45. Valiahdi, S.M.; Iranshahi, M.; Sahebkar, A. Cytotoxic activities of phytochemicals from Ferula species. Daru, 2013, 21(1), 39. doi: 10.1186/2008-2231-21-39 PMID: 23701832
  46. Soltani, S.; Amin, G.; Salehi-Sourmaghi, M.H.; Iranshahi, M. Histone deacetylase inhibitory and cytotoxic activities of the constituents from the roots of three species of Ferula. Iran. J. Basic Med. Sci., 2019, 22(1), 93-98. PMID: 30944714
  47. Zhang, H.; Xu, H.; Ashby, C.R., Jr; Assaraf, Y.G.; Chen, Z.S.; Liu, H.M. Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp). Med. Res. Rev., 2021, 41(1), 525-555. doi: 10.1002/med.21739 PMID: 33047304
  48. Al Khoury, C.; Thoumi, S.; Tokajian, S.; Sinno, A.; Nemer, G.; El Beyrouthy, M.; Rahy, K. ABC transporter inhibition by beauvericin partially overcomes drug resistance in Leishmania tropica. Antimicrob. Agents Chemother., 2024, 68(5), e01368-e23. doi: 10.1128/aac.01368-23 PMID: 38572959
  49. Iranshahi, M.; Barthomeuf, C.; Bayet-Robert, M.; Chollet, P.; Davoodi, D.; Piacente, S.; Rezaee, R.; Sahebkar, A. Drimane-type sesquiterpene coumarins from Ferula gummosa fruits enhance doxorubicin uptake in doxorubicin-resistant human breast cancer cell line. J. Tradit. Complement. Med., 2014, 4(2), 118-125. doi: 10.4103/2225-4110.126181 PMID: 24860735
  50. Khaliq, R.; Iqbal, P.; Wani, A.Y. Colorectal Cancer: Natural Products as a Treatment. In: Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics; IGI Global, 2022; pp. 119-152. doi: 10.4018/978-1-7998-9258-8.ch006
  51. Cheraghi, O.; Dehghan, G.; Mahdavi, M.; Rahbarghazi, R.; Rezabakhsh, A.; Charoudeh, H.N.; Iranshahi, M.; Montazersaheb, S. Potent anti-angiogenic and cytotoxic effect of conferone on human colorectal adenocarcinoma HT-29 cells. Phytomedicine, 2016, 23(4), 398-405. doi: 10.1016/j.phymed.2016.01.015 PMID: 27002410
  52. Neshatia, V.; Matin, M.M.; Iranshahi, M.; Bahrami, A.R.; Behravan, J.; Mollazadeh, S.; Rassouli, F.B. Cytotoxicity of vincristine on the 5637 cell line is enhanced by combination with conferone. Z. Naturforsch. C J. Biosci., 2009, 64(5-6), 317-322. doi: 10.1515/znc-2009-5-602 PMID: 19678531
  53. Maleki, E.H.; Bahrami, A.R.; Sadeghian, H.; Matin, M.M. Discovering the structure–activity relationships of different O-prenylated coumarin derivatives as effective anticancer agents in human cervical cancer cells. Toxicol. In Vitro, 2020, 63, 104745. doi: 10.1016/j.tiv.2019.104745 PMID: 31830504
  54. Kiseleva, V.V.; Nikonov, G.K.; Karryev, M.O. The structure of diversin and diversinin - Coumarins of Ferula diversivittata. Chem. Nat. Compd., 1975, 11(3), 358-361. doi: 10.1007/BF00571206
  55. Haghighitalab, A.; Moghaddam, M.M.; Bahrami, A.R.; Iranshahi, M. In vitro investigation of diversin cytotoxicity on 5637 cells., 2010. Available from: https://profdoc.um.ac.ir/articles/a/1019488.pdf (accessed on 8-10-2024)
  56. Haghighitalab, A.; Matin, M.M.; Bahrami, A.R.; Iranshahi, M.; Saeinasab, M.; Haghighi, F. In vitro investigation of anticancer, cell-cycle-inhibitory, and apoptosis-inducing effects of diversin, a natural prenylated coumarin, on bladder carcinoma cells. Z. Naturforsch. C J. Biosci., 2014, 69(3-4), 99-109. doi: 10.5560/znc.2013-0006 PMID: 24873030
  57. Iranshahi, M.; Sahebkar, A.; Hosseini, S.T.; Takasaki, M.; Konoshima, T.; Tokuda, H. Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. Phytomedicine, 2010, 17(3-4), 269-273. doi: 10.1016/j.phymed.2009.05.020 PMID: 19577457
  58. Miski, M.; Mabry, T.J. Daucane esters from Ferula communis subsp. communis. Phytochemistry, 1985, 24(8), 1735-1741. doi: 10.1016/S0031-9422(00)82543-1
  59. Iranshahi, M.; Rezaee, R.; Najaf, N.M.; Haghbin, A.; Kasaian, J. Cytotoxic activity of the genus Ferula (Apiaceae) and its bioactive constituents. Avicenna J. Phytomed., 2018, 8(4), 296-312. PMID: 30377589
  60. Zanoli, P.; Zavatti, M.; Geminiani, E.; Corsi, L.; Baraldi, M. The phytoestrogen ferutinin affects female sexual behavior modulating ERα expression in the hypothalamus. Behav. Brain Res., 2009, 199(2), 283-287. doi: 10.1016/j.bbr.2008.12.009 PMID: 19124045
  61. Abourashed, E.A.; Galal, A.M.; Shibl, A.M. Antimycobacterial activity of ferutinin alone and in combination with antitubercular drugs against a rapidly growing surrogate of Mycobacterium tuberculosis. Nat. Prod. Res., 2011, 25(12), 1142-1149. doi: 10.1080/14786419.2010.481623 PMID: 21442547
  62. Zavatti, M.; Guida, M.; Maraldi, T.; Beretti, F.; Bertoni, L.; La Sala, G.B.; De Pol, A. Estrogen receptor signaling in the ferutinin-induced osteoblastic differentiation of human amniotic fluid stem cells. Life Sci., 2016, 164, 15-22. doi: 10.1016/j.lfs.2016.09.005 PMID: 27629493
  63. Safi, R.; Rodriguez, F.; Hilal, G.; Diab-Assaf, M.; Diab, Y.; El-Sabban, M.; Najjar, F.; Delfourne, E. Hemisynthesis, antitumoral effect, and molecular docking studies of ferutinin and its analogues. Chem. Biol. Drug Des., 2016, 87(3), 382-397. doi: 10.1111/cbdd.12670 PMID: 26432755
  64. Poli, F.; Appendino, G.; Sacchetti, G.; Ballero, M.; Maggiano, N.; Ranelletti, F.O. Antiproliferative effects of daucane esters from Ferula communis and F. arrigonii on human colon cancer cell lines. Phytother. Res., 2005, 19(2), 152-157. doi: 10.1002/ptr.1443 PMID: 15852493
  65. Arghiani, N.; Matin, M.M.; Bahrami, A.R.; Iranshahi, M.; Sazgarnia, A.; Rassouli, F.B. Investigating anticancer properties of the sesquiterpene ferutinin on colon carcinoma cells, in vitro and in vivo. Life Sci., 2014, 109(2), 87-94. doi: 10.1016/j.lfs.2014.06.006 PMID: 24953605
  66. Matin, M.M.; Nakhaeizadeh, H.; Bahrami, A.R.; Iranshahi, M.; Arghiani, N.; Rassouli, F.B. Ferutinin, an apoptosis inducing terpenoid from Ferula ovina. Asian Pac. J. Cancer Prev., 2014, 15(5), 2123-2128. doi: 10.7314/APJCP.2014.15.5.2123 PMID: 24716944
  67. Tang, J.; Luo, Y.; Tian, Z.; Liao, X.; Cui, Q.; Yang, Q.; Wu, G. TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α. Neoplasia, 2020, 22(9), 343-351. doi: 10.1016/j.neo.2020.06.003 PMID: 32599554
  68. Safi, R.; Hamade, A.; Bteich, N.; El Saghir, J.; Assaf, M.D.; El-Sabban, M.; Najjar, F. A ferutinin analogue with enhanced potency and selectivity against ER-positive breast cancer cells in vitro. Biomed. Pharmacother., 2018, 105, 267-273. doi: 10.1016/j.biopha.2018.05.058 PMID: 29860218
  69. Severini, C.; Mascolo, M.G.; Morandi, E.; Silingardi, P.; Horn, W.; Perdichizzi, S.; Vaccari, M.; Colacci, A. 509 POSTER Evaluation of in vitro toxicity and efficacy of ferutinin, a natural promising chemoprevantive compound. Eur. J. Cancer, Suppl., 2006, 4(12), 155. doi: 10.1016/S1359-6349(06)70514-6
  70. Macrì, R.; Bava, I.; Scarano, F.; Mollace, R.; Musolino, V.; Gliozzi, M.; Greco, M.; Foti, D.; Tucci, L.; Maiuolo, J.; Carresi, C.; Tavernese, A.; Palma, E.; Muscoli, C.; Mollace, V. In vitro evaluation of ferutinin rich-Ferula communis L., ssp. glauca, root extract on doxorubicin-induced cardiotoxicity: Antioxidant properties and cell cycle modulation. Int. J. Mol. Sci., 2023, 24(16), 12735. doi: 10.3390/ijms241612735 PMID: 37628916
  71. Alkhatib, R.; Hennebelle, T.; Joha, S.; Idziorek, T.; Preudhomme, C.; Quesnel, B.; Sahpaz, S.; Bailleul, F. Activity of elaeochytrin A from Ferula elaeochytris on leukemia cell lines. Phytochemistry, 2008, 69(17), 2979-2983. doi: 10.1016/j.phytochem.2008.09.019 PMID: 18992904

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bentham Science Publishers, 2025